20345 - LIFE SCIENCES
CLMG - M - IM - MM - AFC - CLAPI - CLEFIN-FINANCE - CLELI - ACME - DES-ESS - EMIT
Course taught in English
Go to class group/s: 31
This is an advanced course on the management and the strategies of the firms operating in the biopharmaceutical sector. Since biopharma is an emblematic case of a high-tech industry, the course speaks to anyone who is interested in understanding some broad issues about technological entrepreneurship, the relationships between science and industry, intellectual property rights and other themes linked to high-tech sectors.
- Life Sciences: birth and evolution of an industry
- The Business Plan in the Life Sciences industry
- Research and discovery of new compounds
- The formation of biotech companies
- Intellectual property rights
- Technology licensing in biotechnology
- Business models and venture capital
Attending students
The final grade is computed as follows:
- Class Participation & Individual Assignment (10%)
- Group Assignments (20%)
- Final Project (50%)
- Exam (20%)
Non attending students
Written exam
- A. GAMBARDELLA, Science and Innovation. The US pharmaceutical industry during the 1980s, Cambridge University Press, 1995 (Chapters 1, 2, 3 and 4)
- G. PISANO, Science Business: The Promise, the Reality, and the Future of Biotech, Harvard University Press, 2006